Lab of the Future – News and Features

A team has developed low-cost fluorescence-guided surgery goggles using off-the-shelf components, reducing costs from $100,000 to around $1,000. The system uses augmented reality glasses to display tumor locations in real-time during surgery.

A study reveals that a personalized approach, considering age, sex and size, improves the diagnosis of hypertrophic cardiomyopathy (HCM). The new method identifies more women and reduces misdiagnoses, ensuring better treatment opportunities.

New research shows that AI may help pinpoint care needs for hospitalized long COVID patients.

UK Biobank's proteomics study will measure 5,400 proteins in 600,000 samples, tracking changes over mid-to-late life. By combining genetic, imaging and proteomic data, this initiative promises breakthroughs in disease diagnosis and drug discovery.

A study uncovers how H2O2-induced redox modification regulates the RNA demethylase SlALKBH2. This modification stabilizes SlALKBH2 and accelerates tomato ripening without altering its m6A demethylase activity.

A study reveals that 58% of 23-year-olds exhibit disordered eating behaviors, categorized as restrictive or emotional/uncontrolled eating. Researchers linked these patterns to delayed brain maturation, genetic risk and mental health difficulties.

Researchers have identified the Ephesos skull, long speculated to belong to Cleopatra’s sister Arsinoë IV, as a Roman boy aged 11–14. Modern techniques confirmed the skull and femur belonged to a male with developmental anomalies.

This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.

A study by UGR and UPNA highlights early fasting (5 p.m.–9 a.m.) as a safe, effective method for weight loss and improved glucose regulation. Early fasting reduced subcutaneous abdominal fat and improved overnight glucose levels.

Åbo Akademi researchers have enhanced inverted organic solar cells, achieving over 18% efficiency and 24,700 hours of operational life. A thin silicon oxide nitrate (SiOxNy) passivation layer resolved a critical recombination loss mechanism.